Psychogenic and Neurogenic Components in Patients With Psychogenic or Neuropathic Pruritus
NCT ID: NCT05024851
Last Updated: 2024-01-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
40 participants
OBSERVATIONAL
2021-08-25
2022-07-08
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The diagnosis of psychogenic pruritus is often over stated, when no cause is found; therefore, it is important to see what is really relieving from psychic so as not to over-diagnose and adopt a therapy more in line with the real problem of the patient. In daily practice, it seems to have a tendency to separate psychogenic and neurogenic etiologies in the diagnosis of neuropathic or psychogenic pruritus.
In the case of patients with psychogenic pruritus and neuropathic pruritus, no study has attempted to study the respective part of psychogenic and neurogenic components. Consequently, it would therefore be interesting to assess the areas of superposition and distinction of neuropathic and psychogenic pruritus.
The aim of this pilot study is to assess the psychogenic and neurogenic components of psychogenic pruritus and neuropathic pruritus in order to improve understanding of the mechanism and therefore their management.
The main objective of this study is to highlight the differences and the potential common characteristics between psychogenic and neuropathic pruritus in order to improve the differential diagnosis between these two pathologies.
The secondary objective of this study is to describe the psychogenic and neurogenic characteristics of psychogenic and neuropathic pruritus.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Gut Microbiota and Bacterial Translocation in Restless Legs Syndrome
NCT05985421
Subjective Perception of Motor Control During Psychogenic Disorders
NCT02843932
Relationship Between Sensory and Motor Systems in Restless Leg Syndrome
NCT00074672
Autonomic Assessment in Patients With Restless Legs Syndrome
NCT04906486
Ecological Momentary Assessment in Patients With Restless Legs Syndrome
NCT05695963
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The duration of participation is estimated at 1 hour.
Questionnaires used :
* Critères diagnostiques du prurit psychogène (Diagnosis criteria of functional itch disorder or psychogenic pruritus, from the French psychodermatology group)
* NP5 questionnaire
* Questionnaire de Brest
* HADS
* TAS-20
* DN4i
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patients with Psychogenic pruritus
Questionnaires
Evaluation of the Psychogenic and Neurogenic Components using questionnaires
Patients with Neuropathic Pruritus
Questionnaires
Evaluation of the Psychogenic and Neurogenic Components using questionnaires
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Questionnaires
Evaluation of the Psychogenic and Neurogenic Components using questionnaires
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Diagnosis of psychogenic pruritus or neuropathic pruritus made in consultation, in day hospital or in hospital, within the dermatology department at the CHRU de Brest
* Able to understand and agree to sign the information and non-opposition notice
* No opposition of the patient
Exclusion Criteria
* Minor (\<18 years old)
* Acute or chronic condition which could limit the patient's ability to the study's participation
* Inability to understand and sign the information and non-opposition notice
* Refusal to give no opposition
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Brest
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHRU de Brest
Brest, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PRURINEURO (29BRC21.0135)
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.